Literature DB >> 12869678

Treatment of active ankylosing spondylitis with pamidronate.

H Haibel, J Brandt, M Rudwaleit, H Soerensen, J Sieper, J Braun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869678     DOI： 10.1093/rheumatology/keg256

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  16 in total

Review 1.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

2.  Treatment of ankylosing spondylitis with pamidronate: an open label study.

Authors:  R Grover; S Shankar; R Aneja; V Marwaha; R Gupta; A Kumar
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 3.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 4.  Do bisphosphonates and statins have a role in spondyloarthritis management?

Authors:  Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 5.  A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.

Authors:  L Goh; A Samanta
Journal:  Rheumatol Int       Date:  2009-06-28       Impact factor: 2.631

6.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].

Authors:  U Kiltz; J Sieper; H Kellner; D Krause; M Rudwaleit; J-F Chenot; A Stallmach; S Jaresch; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

Review 7.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 8.  Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.

Authors:  Eric Toussirot; Daniel Wendling
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 9.  Pamidronate treatment in rheumatology practice: a comprehensive review.

Authors:  Gleb Slobodin; Itzhak Rosner; Joy Feld; Doron Rimar; Michael Rozenbaum; Nina Boulman; Majed Odeh
Journal:  Clin Rheumatol       Date:  2009-08-19       Impact factor: 2.980

10.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.